The global allergy immunotherapy market is expected to be valued at US$ 1,949.2 Mn in 2020 and growing at a CAGR of 9.4% over the forecast period to reach US$ 3,381.7 Mn by 2027 owing to growing occurrence of sensitivities such as allergies and ineffective treatment procedures, such as pharmacotherapy, to control the prevalence rate of allergies are the major factors boosting the adoption of allergy immunotherapy Market, which is considered as a designated treatment for various types of allergies. Increasing death rates due to allergies is the main reason due to which government is supporting to invest in research and development to provide the better and improved treatment options for the patients. Allergy immunotherapy is a treatment that prevents allergic reactions from a variety of sources, including food, grass pollen, dust, and bee venom. Allergy immunotherapy helps people with allergies such as rhinitis, asthma, and conjunctivitis, among other allergies, regulate their symptoms. Allergy immunotherapy is regular injections that gradually increase the dosage in order to create resistance in the patient. Because of the increased creation of blocking antibodies that combat the foreign chemicals that cause allergies, the patient’s immunity system becomes less brittle when the dosage is gradually increased.